5 Steps of FDA Approvals

  • Home
  • 5 Steps of FDA Approvals

5 Steps of FDA Approvals

5 Steps of FDA Approvals

The U.S. Food and Drug Administration (FDA) follows a structured process to ensure that drugs are safe, effective, and high-quality before they reach patients.


1. Preclinical Testing (Laboratory & Animal Studies)

  • Conducted before human trials.

  • Purpose: Assess safety, toxicity, pharmacology, and efficacy signals.

  • Data generated is used to file an Investigational New Drug (IND) application with the FDA.


2. Investigational New Drug (IND) Application

  • Submitted to FDA before starting clinical trials.

  • Contains preclinical data, manufacturing details, and clinical trial protocols.

  • FDA reviews the IND (typically within 30 days) to ensure it is safe to proceed with human trials.


3. Clinical Trials (Human Testing)

Divided into 3 phases:

  • Phase I: Small group (20–100 healthy volunteers or patients). Focus on safety, dosage, and pharmacokinetics.

  • Phase II: Larger group (100–500 patients). Focus on efficacy and side effects.

  • Phase III: Large-scale studies (1,000+ patients). Confirm efficacy, monitor adverse effects, compare with standard treatments.

If successful, sponsor files a New Drug Application (NDA) or Biologics License Application (BLA).


4. FDA Review of NDA/BLA

  • FDA evaluates all submitted data:

    • Clinical trial results

    • Manufacturing and facility compliance (cGMP inspections)

    • Labeling (accuracy, clarity, safety info)

  • Expert advisory committees may be consulted.

  • Standard review: ~10 months; Priority review: ~6 months.


5. FDA Post-Market Surveillance (Phase IV)

  • After approval, FDA continues monitoring through:

    • MedWatch reports (adverse events)

    • Post-marketing studies (Phase IV commitments)

    • Inspections of manufacturing facilities

  • If risks outweigh benefits, FDA can issue label changes, restrictions, or product recalls.


Summary
The 5 steps of FDA approvals are:

  1. Preclinical Testing

  2. IND Application

  3. Clinical Trials (Phases I–III)

  4. FDA Review of NDA/BLA

  5. Post-Market Surveillance (Phase IV)

🎓 Discover one of the best Complete Pharmaceutical Quality Assurance Course available —click below to explore the course that’s shaping future in QA Course skills.

https://trcjw.on-app.in/app/oc/306166/trcjw?utm_source%3Dcopy-link%26utm_medium%3Dtutor-course-referral%26utm_campaign%3Dcourse-overview-app

Submit a Comment

Your email address will not be published. Required fields are marked *


The reCAPTCHA verification period has expired. Please reload the page.

Hello
Chat now via Whatsapp